v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
Total
Shareholders' Equity [Member]
Common Stock [Member]
Add'l Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accum. Other Comp. Loss [Member]
Noncontrolling Interests [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     9,407          
Beginning balance at Dec. 31, 2020 $ 63,473 $ 63,238 $ 470 $ 88,674 $ (110,988) $ 90,392 $ (5,310) $ 235
Beginning balance (in shares) at Dec. 31, 2020         (3,840)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 18,633 18,586       18,586   47
Other comprehensive income/(loss), net of tax (338) (338)         (338)  
Cash dividends declared, per share                
Common stock (6,569) (6,569)       (6,569)    
Noncontrolling interests (8)             (8)
Share-based payment transactions (in shares)     56   11      
Share-based payment transactions 855 855 $ 3 1,300 $ (371) (77)    
Purchases of common stock 0              
Other (79) (81)       (81)   1
Ending balance (in shares) at Oct. 03, 2021     9,462          
Ending balance at Oct. 03, 2021 75,967 75,691 $ 473 89,973 $ (111,359) 102,252 (5,649) 275
Ending balance (in shares) at Oct. 03, 2021         (3,851)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     9,450          
Beginning balance at Jul. 04, 2021 70,315 70,042 $ 472 89,336 $ (111,356) 96,346 (4,758) 273
Beginning balance (in shares) at Jul. 04, 2021         (3,851)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 8,159 8,146       8,146   12
Other comprehensive income/(loss), net of tax (894) (891)         (891) (3)
Cash dividends declared, per share                
Common stock (2,192) (2,192)       (2,192)    
Noncontrolling interests (8)             (8)
Share-based payment transactions (in shares)     13          
Share-based payment transactions 634 634 $ 1 637 $ (3) (1)    
Purchases of common stock 0              
Other (46) (47)       (47)   1
Ending balance (in shares) at Oct. 03, 2021     9,462          
Ending balance at Oct. 03, 2021 75,967 75,691 $ 473 89,973 $ (111,359) 102,252 (5,649) 275
Ending balance (in shares) at Oct. 03, 2021         (3,851)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     9,462          
Beginning balance (in shares)     9,471          
Beginning balance at Dec. 31, 2021 77,462 77,201 $ 473 90,591 $ (111,361) 103,394 (5,897) 262
Beginning balance (in shares) at Dec. 31, 2021         (3,851)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 26,404 26,378       26,378   27
Other comprehensive income/(loss), net of tax (2,339) (2,328)         (2,328) [1] (11)
Cash dividends declared, per share                
Common stock (6,734) (6,734)       (6,734)    
Noncontrolling interests (7)             (7)
Share-based payment transactions (in shares)     45   12      
Share-based payment transactions 108 108 $ 2 760 $ (584) (71)    
Purchases of common stock (in shares)         (39)      
Purchases of common stock (2,000) (2,000)     $ (2,000)      
Other (4) 7   7   0   (11)
Ending balance (in shares) at Oct. 02, 2022     9,515          
Ending balance at Oct. 02, 2022 92,891 92,631 $ 476 91,359 $ (113,945) 122,967 (8,225) 259
Ending balance (in shares) at Oct. 02, 2022         (3,903)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     9,496          
Beginning balance at Jul. 03, 2022 87,469 87,208 $ 476 91,183 $ (113,939) 116,608 (7,119) 261
Beginning balance (in shares) at Jul. 03, 2022         (3,903)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 8,623 8,608       8,608   15
Other comprehensive income/(loss), net of tax (1,111) (1,106)         (1,106) (5)
Cash dividends declared, per share                
Common stock (2,245) (2,245)       (2,245)    
Noncontrolling interests (7)             (7)
Share-based payment transactions (in shares)     20          
Share-based payment transactions 161 161   172 $ (6) (5)    
Purchases of common stock 0              
Other 0 4   4       (4)
Ending balance (in shares) at Oct. 02, 2022     9,515          
Ending balance at Oct. 02, 2022 $ 92,891 $ 92,631 $ 476 $ 91,359 $ (113,945) $ 122,967 $ (8,225) $ 259
Ending balance (in shares) at Oct. 02, 2022         (3,903)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     9,515          
[1] Amounts do not include foreign currency translation adjustments attributable to noncontrolling interests. Foreign currency translation adjustments include net losses related to our equity method investment in Haleon/the Consumer Healthcare JV (see Note 2C) and the impact of our net investment hedging program.